Tg Therapeutics (TGTX) Operating Leases (2019 - 2026)
Tg Therapeutics (TGTX) posted quarterly Operating Leases of $6.6 million for Q1 2026, down 16.09% year-over-year from $7.9 million in Q1 2025, and down 6.07% quarter-over-quarter from $7.0 million in Q4 2025.
Tg Therapeutics (TGTX) Operating Leases (2019 - 2026) Analysis & Trends
Tg Therapeutics' Operating Leases history runs 8 years deep, the most recent figure standing at $6.6 million for Q1 2026.
- In Q1 2026, Operating Leases fell 16.09% year-over-year to $6.6 million; the TTM figure through Mar 2026 stood at $6.6 million (down 16.09% YoY), while the FY2025 annual figure was $7.0 million, down 13.67% from the prior year.
- Operating Leases for Q1 2026 stood at $6.6 million, down from $7.0 million in the prior quarter.
- The five-year high for Operating Leases was $10.6 million in Q3 2022, with the low at $6.6 million in Q1 2026.
- The 5-year median for Operating Leases is $9.0 million (2024), against an average of $8.8 million.
- The sharpest annual moves came in 2022 and 2026: Operating Leases gained 5.61% in 2022, then slipped 16.09% in 2026.
- Tg Therapeutics' Operating Leases stood at $10.3 million in 2022, then slipped by 10.76% to $9.2 million in 2023, then slipped by 11.89% to $8.1 million in 2024, then fell by 13.67% to $7.0 million in 2025, then fell by 6.07% to $6.6 million in 2026.
- Business Quant data shows TGTX's Operating Leases at $6.6 million in Q1 2026, $7.0 million in Q4 2025, and $7.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.14 Mn |
| Mar 31, 2026 | 6.60 Mn |
| Dec 31, 2025 | 7.02 Mn |
| Sep 30, 2025 | 7.31 Mn |
| Jun 30, 2025 | 7.59 Mn |
| Mar 31, 2025 | 7.86 Mn |
| Dec 31, 2024 | 8.13 Mn |
| Sep 30, 2024 | 8.42 Mn |
| Jun 30, 2024 | 8.70 Mn |
| Mar 31, 2024 | 8.96 Mn |
| Dec 31, 2023 | 9.23 Mn |
| Sep 30, 2023 | 9.52 Mn |
| Jun 30, 2023 | 9.81 Mn |
| Mar 31, 2023 | 10.08 Mn |
| Dec 31, 2022 | 10.34 Mn |
| Sep 30, 2022 | 10.58 Mn |
| Jun 30, 2022 | 9.98 Mn |
| Mar 31, 2022 | 10.32 Mn |
| Dec 31, 2021 | 9.85 Mn |
| Sep 30, 2021 | 10.02 Mn |